Page results
-
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This page explains what extravasation is, and outlines the steps we take when it occurs.
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
You can make a secure payment using our online portal. It is a convenient way to make a payment for a range of services and is available 24/7. When making a payment you will be directed a secure website hosted by The Access Group, a leading provider of business software. Payments can be made against an invoice raised by the Trust or for a range of other services which are set out when you access the portal.
-
A drop-in service providing support, practical advice and information.
-
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
-
A guide created by The Red Cell Network with expert patient insight from Elaine Tappin, Miriam Santos Freire and Nneka Smith.
-
We run dedicated follow up clinics for brain injured patients, either following discharge from hospital or the emergency department.
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
File results
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services